These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


84 related items for PubMed ID: 1772046

  • 1. [Infiltrating transitional carcinoma of the bladder. 3. Effect of regional lymph node dissemination on the prognosis].
    Escudero Barrilero A, Mateos A, Maganto E, Mayayo T, Pérez Bustamante I, Fernández I, del Hoyo J.
    Actas Urol Esp; 1991; 15(4):331-7. PubMed ID: 1772046
    [Abstract] [Full Text] [Related]

  • 2. [Infiltrating transitional carcinoma of the bladder (I). Comparison of 2 groups treated with preoperative radiotherapy (long-term protocol and short-term protocol) + radical cystectomy versus radical cystectomy only. Analysis of local recurrence and metastasis].
    Escudero Barrilero A, Allona A, Berenguer A, Burgos J, Castañeda A, Negrin A, Tellez M.
    Actas Urol Esp; 1991; 15(2):124-38. PubMed ID: 1807106
    [Abstract] [Full Text] [Related]

  • 3. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K, Poulsen AL.
    J Urol; 2007 Oct; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [Abstract] [Full Text] [Related]

  • 4. [Transitional infiltrating carcinoma of the bladder significant in its spread to regional lymph nodes].
    Escudero Barrilero A, Platas A, Jiménez M, Ruiz C, Fernández A, Rodríguez Luna JM, Maganto E, Romero J.
    Arch Esp Urol; 1989 May; 42(4):345-52. PubMed ID: 2782964
    [Abstract] [Full Text] [Related]

  • 5. [Prognosis in pT3b infiltrating tumors of the bladder treated by adjuvant chemotherapy].
    Sahwi A, Robert M, Delbos O, Legouffe E, Guiter J, Navratil H.
    Prog Urol; 1998 Dec; 8(6):1007-11. PubMed ID: 9894259
    [Abstract] [Full Text] [Related]

  • 6. Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only.
    de Vries RR, Nieuwenhuijzen JA, Meinhardt W, Bais EM, Horenblas S.
    Eur J Surg Oncol; 2009 Apr; 35(4):352-5. PubMed ID: 18722076
    [Abstract] [Full Text] [Related]

  • 7. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF, Karakiewicz PI, Palapattu GS, Lotan Y, Rogers CG, Amiel GE, Vazina A, Gupta A, Bastian PJ, Sagalowsky AI, Schoenberg MP, Lerner SP.
    J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [Abstract] [Full Text] [Related]

  • 8. Role of lymph node density in predicting survival of patients with lymph node metastases after radical cystectomy: a multi-institutional study.
    Osawa T, Abe T, Shinohara N, Harabayashi T, Sazawa A, Kubota K, Matsuno Y, Shibata T, Shinno Y, Kamota S, Minami K, Sakashita S, Kumagai A, Mori T, Nonomura K.
    Int J Urol; 2009 Mar; 16(3):274-8; discussion 278. PubMed ID: 19087211
    [Abstract] [Full Text] [Related]

  • 9. [Infiltrating transitional carcinoma of the bladder (4). Our approach to stage pT2 and critique of other risk factors. Multifactorial analysis].
    Escudero Barrilero A, Perales L, Romero J, Rodríguez Luna JM, Vallejo J, Rivas JA.
    Actas Urol Esp; 1991 Mar; 15(5):411-20. PubMed ID: 1807119
    [Abstract] [Full Text] [Related]

  • 10. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy.
    Wright JL, Lin DW, Porter MP.
    Cancer; 2008 Jun; 112(11):2401-8. PubMed ID: 18383515
    [Abstract] [Full Text] [Related]

  • 11. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M.
    Ann Acad Med Stetin; 2000 Jun; 46():217-29. PubMed ID: 11712306
    [Abstract] [Full Text] [Related]

  • 12. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ, Stein JP, Cai J, Miranda G, Groshen S, Skinner DG.
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [Abstract] [Full Text] [Related]

  • 13. [Analysis of 34 cases of infiltrating carcinoma of the bladder treated exclusively with partial cystectomy (part 1)].
    Escudero Barrilero A, Fernández Fernández E, Jiménez Cidre M, Maganto Pavón E, Mayayo Dehesa T, Rodríguez Rodríguez R, Galvis San Juan F, Burgos Revilla FJ.
    Arch Esp Urol; 1996 May; 49(4):349-64. PubMed ID: 8754191
    [Abstract] [Full Text] [Related]

  • 14. [Infiltrating bladder carcinoma with metastatic lymph node involvement: radical treatment and survival].
    de Castro Barbosa F, Sánchez de la Muela P, Rosell Costa D, Aguera Fernández L, Isa Kroon W, Robles García JE, Zudaire Bergera JJ, Berián Polo JM.
    Actas Urol Esp; 1992 Jan; 16(1):58-62. PubMed ID: 1590075
    [Abstract] [Full Text] [Related]

  • 15. Is there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection in metastatic transitional cell carcinoma of the bladder?
    Sweeney P, Millikan R, Donat M, Wood CG, Radtke AS, Pettaway CA, Grossman HB, Dinney CP, Swanson DA, Pisters LL.
    J Urol; 2003 Jun; 169(6):2113-7. PubMed ID: 12771730
    [Abstract] [Full Text] [Related]

  • 16. The role of lymphadenectomy in high-grade invasive bladder cancer.
    Stein JP, Skinner DG.
    Urol Clin North Am; 2005 May; 32(2):187-97. PubMed ID: 15862616
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy.
    Park J, Park S, Song C, Doo C, Cho YM, Ahn H, Kim CS.
    Urology; 2007 Aug; 70(2):257-62. PubMed ID: 17826485
    [Abstract] [Full Text] [Related]

  • 18. The presence of lymphovascular invasion in radical cystectomy specimens from patients with urothelial carcinoma portends a poor clinical prognosis.
    Canter D, Guzzo T, Resnick M, Magerfleisch L, Sonnad S, Bergey M, Tomazewski J, Vaughn D, Van Arsdalen K, Malkowicz B.
    BJU Int; 2008 Sep; 102(8):952-7. PubMed ID: 18485042
    [Abstract] [Full Text] [Related]

  • 19. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy.
    Mills RD, Turner WH, Fleischmann A, Markwalder R, Thalmann GN, Studer UE.
    J Urol; 2001 Jul; 166(1):19-23. PubMed ID: 11435814
    [Abstract] [Full Text] [Related]

  • 20. [New markers for pharmacological targeting in bladder cancer with lymph node metastasis].
    Herrmann E, Eltze E, Köpke T, Bolenz C, Bierer S, Neumann J, Hertle L, Wülfing C.
    Aktuelle Urol; 2007 Sep; 38(5):392-7. PubMed ID: 17907066
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.